Cytotoxic effects induced by treatment with the MCL1 inhibitor S63845 (100 nM) were significant in 12 AML, the MDS sample and 1 B-ALL, with further enhancement in combination with AC-4-130 (Figure S2C). This evidence concerns the gene MCL1 and acute lymphoblastic leukemia.